Recro Pharma (NASDAQ:REPH) is a specialty biopharmaceutical company developing differentiated, high value, prescription drugs for analgesia, anesthesia, sedation and other specialty markets. Recro is currently focusing on proprietary drug solutions for chronic pain, breakthrough pain, and acute post-operative pain.
Location: United States, Pennsylvania, Malvern
Member count: 201-500
Founded date: 2007
Investors 1
| Date | Name | Website |
| - | SCP Vitali... | scpvitalif... |
Mentions in press and media 5
| Date | Title | Description | Category | Author | Source |
| 21.03.2022 | After acqu... | The team at Recro, a CDMO base... | - | Josh Sulli... | endpts.com... |
| 10.11.2021 | Recro Repo... | Acquisition of IriSys, Inc. Si... | - | - | marketscre... |
| 10.11.2021 | Recro Repo... | Recro Reports Third Quarter 20... | - | - | marketscre... |
| 09.08.2021 | Recro Phar... | Q2 2021 Highlighted by Revenue... | - | - | marketscre... |
| 29.06.2016 | The biotec... | There was a time after the 20... | Financing | John Carro... | endpts.com... |